Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic MelanomaWim H.J. Kruit, Ulrich Keilholz, Brigitte Dréno et al.|Journal of Clinical Oncology|2013Cited by 222
Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancerAnne Flament, Frédéric Lehmann|Annals of Oncology|2018Cited by 1